Company: ANIX
Filing Date: 2025-05-28
Form Type: 10-Q
Source: 0001641172-25-012701
Chunk: 27

Company: Anixa Biosciences Inc
Filing Date: 2025-05-28
Form: 10-Q
Item: Part I, Item 8
Chunk 27
---
 in Note 7 of the condensed consolidated financial statements, included elsewhere in this Report.

Item 3. Quantitative and Qualitative Disclosures
About Market Risk. Not applicable.

Item 4. Controls and Procedures.

We carried out an evaluation,
under the supervision and with the participation of our management including our Chief Executive Officer and our Chief Financial Officer,
of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Rule 13(a)-15(b) of the Exchange
Act. Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and
procedures are effective as of the end of the period covered by this Report.

There was no change in our internal
control over financial reporting during the three months ended April 30, 2025, that has materially affected, or is reasonably likely to
materially affect, our internal control over financial reporting.

21

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

Other than lawsuits related to
the enforcement of our patent rights, we are not a party to any material pending legal proceedings, nor are we aware of any pending litigation
or legal proceeding against us that would have a material adverse effect upon our results of operations or financial condition.

Item 1A. Risk Factors.

There have been no material changes
in our risk factors from those disclosed in our Annual Report on Form 10-K for the fiscal year ended October 31, 2024.

Item 2. Unregistered Sales of Equity Securities
and Use of Proceeds. None.

Item 3. Defaults Upon Senior Securities.
None.

Item 4. Mine Safety Disclosures.
Not Applicable.

Item 5. Other Information. None.

Item 6. Exhibits.

    31.1
    Certification of Chief Executive Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated May 28, 2025.

    31.2
    Certification of Chief Financial Officer, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, dated May 28, 2025.

    32.1
    Statement of Chief Executive Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated May 28, 2025.

    32.2
    Statement
    of Chief Financial Officer, pursuant to Section 1350 of Title 18 of the United States Code, dated May